These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9499321)

  • 1. [Hallervorden-Spatz disease and botulinum toxin].
    Riol Diego M; Narbona García J
    An Esp Pediatr; 1997 Oct; 47(4):443-4. PubMed ID: 9499321
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.
    Dressler D; Wittstock M; Benecke R
    Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of botulinum toxin A treatment in a case of pantothenate kinase associated neurodegeneration (PKAN).
    Crisci C; Esposito M
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22689279
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallervorden Spatz disease.
    Sabat SB; Deshmukh MP
    J Assoc Physicians India; 2006 Aug; 54():629. PubMed ID: 16941794
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin: from life-threatening disease to novel medical therapy.
    Mahajan ST; Brubaker L
    Am J Obstet Gynecol; 2007 Jan; 196(1):7-15. PubMed ID: 17240220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in association with other rejuvenation methods.
    de Maio M
    J Cosmet Laser Ther; 2003 Dec; 5(3-4):210-2. PubMed ID: 14741834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A; Rodrigues B; Nóbrega AC
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in botulinum toxin applications].
    Zaleski P
    Pol Merkur Lekarski; 1999 Sep; 7(39):134-7. PubMed ID: 10598494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cutaneous uses for botulinum toxin type A.
    Bansal C; Omlin KJ; Hayes CM; Rohrer TE
    J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A's efficacy in nummular headache.
    Dusitanond P; Young W
    Headache; 2008 Oct; 48(9):1379. PubMed ID: 19006552
    [No Abstract]   [Full Text] [Related]  

  • 11. Migraine, botulinum toxin type-A, and the disappearing sebaceous cyst.
    Turner IM; Agrillo T
    Headache; 2005 Feb; 45(2):166-7. PubMed ID: 15705125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study.
    Sycha T; Graninger M; Auff E; Schnider P
    Eur J Clin Invest; 2004 Apr; 34(4):312-3. PubMed ID: 15086364
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Benohanian A
    Br J Dermatol; 2005 Aug; 153(2):460-1; author reply 461. PubMed ID: 16086777
    [No Abstract]   [Full Text] [Related]  

  • 15. Worldwide experience with botulinum toxin type A.
    Karsenti G
    J Cosmet Laser Ther; 2003 Dec; 5(3-4):208-9. PubMed ID: 14741833
    [No Abstract]   [Full Text] [Related]  

  • 16. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S; Ryan P; Sleeman D
    J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of botulinum toxin-A in the treatment of patients with fibromyalgia.
    Asherson RA; Pascoe L
    J Rheumatol; 2001 Jul; 28(7):1740. PubMed ID: 11469493
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin is helpful in aquagenic palmoplantar keratoderma.
    Diba VC; Cormack GC; Burrows NP
    Br J Dermatol; 2005 Feb; 152(2):394-5. PubMed ID: 15727674
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin type A for the treatment of headache: why we say yes.
    Ashkenazi A; Silberstein S
    Arch Neurol; 2008 Jan; 65(1):146-9. PubMed ID: 18195155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.